The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| MDRX | -47.62% | -57.79% | -15.85% | -13% |
| S&P | +15.06% | +95.03% | +14.29% | +571% |
Veradigm, Inc. engages in the provision of clinical, financial, and operational results services. It operates through the Provider and Veradigm segments. The Provider segment includes the hospitals and health systems, ambulatory, CarePort, FollowMyHealth, EPSiTM, EISClassics, and 2bPrecise strategic business units. The firm solutions include All EMRs, All Population Health Management, Patient Engagement, and Precision Medicine. The company was founded in 1986 and is headquartered in Chicago, IL.
If the company's latest set of preliminary results is any indication, it had a far better than expected Q4 and full-year 2021.
Here's why the healthcare technology provider narrowly beat analysts' earnings estimates in Q2 but missed on revenue expectations.
Currently no data to display
Currently no data to display.
Currently no data to display.
| Metric | YoY Change |
|---|
MDRX earnings call for the period ending September 30, 2021.
MDRX earnings call for the period ending June 30, 2021.
MDRX earnings call for the period ending December 31, 2020.
MDRX earnings call for the period ending December 31, 2020.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
